Reduced central serotonin transporters in alcoholism

American Journal of Psychiatry

Volumn 155, Issue 11, 1998, Pages 1544-1549

  Heinz, Andreas ^a   Ragan, Paul ^b   Jones, Douglas W ^b   Hommer, Dan ^b   Williams, Wendol ^b   Knable, Michael B ^b   Gorey, Julia G ^b   Doty, Linda ^b   Geyer, Christopher ^b   Lee, Kan S ^b   Coppola, Richard ^b   Weinberger, Daniel R ^b   Linnoila, Markku ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLISM; ANXIETY; ARTICLE; DEPRESSION; HUMAN; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031730864     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.11.1544     Document Type: Article

References (51)

1. Cloninger CR: Neurogenetic adaptive mechanisms in alcoholism. Science 1987; 236:410-416
2. Wise RA: The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol 1988; 97:118-132
3. LeMarquandt D, Pihl RO, Benkelfat C: Serotonin and alcohol intake, abuse, and dependence: findings in animal studies. Biol Psychiatry 1994; 36:395-421
4. Mereau G, Fadda F, Gessa GL: Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats. Brain Res 1984; 292:63-69
5. Imperato A, Di Chiara G: Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 1986; 239:219-228
6. Mash DC, Staley JK, Doepel FM, Young SN, Ervin FR, Palmour RM: Altered dopamine transporter densities in alcohol-preferring vervet monkeys. Neuroreport 1996; 7:457-462
7. Eshleman AJ, Henningsen RA, Neve KA, Janowsky A: Release of dopamine via the human transporter. Mol Pharmacol 1993; 45:312-316
8. Tiihonen J, Kuikka J, Bergstroem K, Hakola P, Karhu J, Ryynaenen OP, Foehr J: Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nature Med 1995; 1:654-657
9. Hietala J, West C, Sylvalahti E, Njagren K, Lehikionen P, Sonninen P, Routsalainen U: Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacol (Berl) 1994; 116:285-290
10. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding JS, Pappas N, Shea C, Piscani K: Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 1996; 20:1594-1598
11. Dettling M, Heinz A, Dufeu P, Rommelspacher H, Gräf K-J, Schmidt LG: Dopaminergic responsivity in alcoholism: trait, state, or residual marker? Am J Psychiatry 1995; 152:1317-1321
12. Heinz A, Dufeu P, Kuhn S, Dettling M, Gräf K-J, Kuerten I, Rommelspacher H, Schmidt LG: Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients. Arch Gen Psychiatry 1996; 53:1123-1128
13. 1B receptors. Alcohol Clin Exp Res 1996; 20:1401-1405
14. Panocka I, Massi M: Long-lasting suppression of alcohol preference in rats following serotonin receptor blockade by ritanserin. Brain Res Bull 1992; 28:493-496
15. Higley JD, Suomi SJ, Linnoila M: A non-human primate model of type II excessive alcohol consumption? parts 1, 2. Alcohol Clin Exp Res 1996; 20:629-651
16. Virkunnen M, Kallio E, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C, Bissette G, Kalogeras K, Karonen SL, Linnoila M: Personality profiles and state aggressiveness in Finnish alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 1994; 51:28-33
17. Fils-Aime ML, Eckhardt MJ, George DT, Brown GL, Mefford I, Linnoila M: Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics. Arch Gen Psychiatry 1996; 53:211-216
18. Goldman D: Why mice drink. Nature Genet 1996; 13:137-138
19. Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, Al-Tikriti MS, Sybirska MH, Zimmermann RC, Wiesniewski G, Neumeyer JL, Milius RA, Wang S, Smith EO, Roth RH, Charney DS, Hoffer PB, Innis RB: SPECT imaging of dopamine and serotonin transporters with [123-I]β-CIT: pharmacological characterization of brain uptake in non-human primates. Synapse 1993; 13:295-309
20. Pirker W, Asenbaum S, Kasper S, Walter H, Angelberger P, Koch G, Pozzera A, Deecke L, Podreka I, Bruecke T: β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. J Neural Transm 1995; 100: 247-256
21. Jagust WJ, Eberling JL, Biegon A, Taylor SE, Van Brocklin HF, Jordan S, Hanrahan SM, Roberts JA, Brennan KM, Mathis CA: Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter. J Nucl Med 1996; 37: 1207-1214
22. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R: Inhibition of monoamine oxidase B in the brain of smokers. Nature 1996; 379:733-736
23. Pich M, Pagliusi SR, Tessari M, Talabot-Ayer D, Hooft van Huisen R, Chiamulera C: Common neural substrates for the addictive properties of nicotine and cocaine. Science 1997; 275:83-86
24. LeMarquandt D, Pihl RO, Benkelfat C: Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biol Psychiatry 1994; 36:326-337
25. Heinz A, Lichtenberg-Kraag B, Saellstroem Baum S, Graef K, Krueger F, Dettling M, Rommelspacher H: Evidence for prolonged recovery of dopaminergic transmission after detoxification in alcoholics with poor treatment outcome. J Neural Transm Gen Sect 1995; 102:149-157
26. Chapman LJ, Chapman JP, Numbers JF, Edell WS, Carpenter BN, Beckfield D: Impulsive nonconformity as a trait contributing to the prediction of psychoticlike and schizotypal symptoms. J Nerv Ment Dis 1984; 172:681-691
27. Andreasen NC: Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry 1982; 39:784-788
28. Spielberger CD, Gorsuch RL, Lushene RD: STAI Manual. Palo Alto, Calif, Consulting Psychologists Press, 1970
29. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571
30. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
31. Seibyl JP, Wallace E, Smith EO, Stabin M, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Gao Y, Zhang WY, Neumeyer JL, Zubal IG, Charney DS, Hoffer PB, Innis RB: Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-β-CIT in healthy human subjects. J Nucl Med 1994; 35:764-770
32. Baldwin RM, Zea-Ponce Y, Zoghbi SS, Laruelle M, Al-Tikritti MS, Sybirska EH, Malison RT, Neumeyer JL, Milius RA, Wang S, Stabin M, Smith EO, Charney DS, Hoffer PB, Innis RB: Evaluation of the monoamine uptake site ligand [123-I]methyl 3β-(iodophenyl)-tropane-2β-carboxylate ([123-I]β-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI. Nucl Med Biol 1993; 5:597-606
33. Jones DW, Heinz A, Gorey JG, Lee KS, Knable MB, Urbina RA, Weinberger DR: A simple, sensitive, and efficient method of directly determining plasma concentrations of the free [I-123]β-CIT at extended times by TLC of ultrafiltrates (abstract). J Nucl Med 1997; 38(suppl):287
34. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI: The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 1995; 15:1714-1723
35. Laruelle M, Wallace E, Seibyl JP, Baldwin RM, Zea-Ponce Y, Zoghbi SS, Neumeyer JL, Charney DS, Hoffer PB, Innis RB: Graphical, kinetic, and equilibrium analyses of in vivo [123-I]β-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 1994; 14:982-994
36. Baumgarten HG, Grozdanovic Z: Psychopharmacology of central serotonergic systems. Pharmacopsychiatry 1995; 28(suppl 2):73-79
37. Fisher RE, Morris ED, Alpert NM, Fischman AJ: In vivo imaging of neuromodulatory synaptic transmission using PET: a review of relevant neurophysiology. Human Brain Map 1995; 3:24-34
38. 11C]cocaine binding to decreases in synaptic dopamine. Synapse 1995; 20:137-144
39. 11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine. Eur J Pharmacol 1995; 281:141-149
40. Ballenger JC, Goodwin FK, Major LF, Brown GL: Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry 1979; 36:224-227
41. 3 antagonist on drug-induced stimulation of dopamine release (abstract). Eur J Pharmacol 1989; 164:515
42. Wallis CJ, Rezazadeh SM, Lal H: Role of serotonin in ethanol abuse. Drug Dev Res 1993; 30:178-188
43. Rossetti ZL, Melis F, Carboni S, Diana M, Gessa GL: Alcohol withdrawal in rats is associated with a marked decrease in extraneural dopamine. Alcohol Clin Exp Res 1992; 16:529-532
44. Hawley RJ, Major LF, Schulman EA, Linnoila M: Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal: correlations with clinical signs. Arch Gen Psychiatry 1985; 42:1056-1062
45. Yu A, Yang J, Pawlyk AC, Tejani-Butt SM: Acute depletion of serotonin down-regulates serotonin-transporter mRNA in raphe neurons. Brain Res 1995; 688:209-212
46. Rattray M, Baldessari S, Gobbi M, Mennini T, Samanin R, Bendotti C: p-Chlorphenylalanine changes serotonin transporter mRNA levels and expression of the gene product. J Neurochem 1996; 67:463-472
47. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Mueller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531
48. Gray JA: The Neuropsychology of Anxiety: An Inquiry Into the Functions of the Septo-Hippocampal System. New York, Oxford University Press, 1982, pp 301-406
49. Cloninger CR: A systematic method for clinical description and classification of personality variants: a proposal. Arch Gen Psychiatry 1987; 44:573-588
50. Anderson IM, Tomenson BM: The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 1994; 8:238-249
51. Hartka E, Johnstone B, Leino EV, Motoyoshi M, Temple MT, Fillmore KM: The collaborative alcohol-related longitudinal project: a meta-analysis of depressive symptomatology and alcohol consumption over time. Br J Addict 1991; 86:1283-1298